Treace Medical Concepts (TMCI) Net Cash Flow (2020 - 2026)

Treace Medical Concepts has reported Net Cash Flow for 7 years, with the latest figure at -$1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 157.57% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$3.8 million (down 194.8% YoY), and the FY2025 full-year result was -$642000.0, up 60.66% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$1.2 million, down from $3.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $10.1 million in Q1 2023, with the low at -$69.1 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$5.7 million across 5 years, with a median of -$1.2 million in 2026.
• Annual changes were most pronounced in 2022 — Net Cash Flow sank 1783.64% — and 2025, when it jumped 497.63%.
• Treace Medical Concepts' Net Cash Flow stood at -$69.1 million in 2022, then surged by 108.26% to $5.7 million in 2023, then sank by 113.32% to -$760000.0 in 2024, then jumped by 497.63% to $3.0 million in 2025, then slumped by 138.52% to -$1.2 million in 2026.
• The last three Net Cash Flow figures came in at -$1.2 million (Q1 2026), $3.0 million (Q4 2025), and -$366000.0 (Q3 2025), per Business Quant data.